Conditions and Treatments
- Adjunct Professor, Department of Medicine
- American Board of Internal Medicine (Gastroenterology), 1987
- American Board of Internal Medicine - Internal Medicine, 1980
Education and Training
- Fellowship, NYU Medical Center, Gastroenterology, 1983
- Residency, NYU Medical Center, 1981
- MD from New York University, 1978
Locations and Appointments
- Cigna PPO
- Empire BC/BS
- Empire NYS Plan
- GHI HMO
- LOCAL 1199 PPO
- NY MEDICAID
- Oxford Freedom
- Oxford Liberty
- Oxford Medicare
- UnitedHealthcare Medicare
- UnitedHealthcare Top Tier
Research My Research
Spector, S., Weingeist, T., Pollard, R.B., et al. A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J. Infect. Dis. 1993; 168:557-560.
Dieterich D.T., Poles, M.A., Lew, E.A., et al. Concurrentl use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J. Infect. Dis. 1993; 167: 1184-1188.
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. 4. Visual Outcomes. Ophthalmology. 1994; 101: 1250-1261.
Studies of Ocular complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial-3. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch. Int. Med. 1995;155: 65-74.
Studies of Ocular complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Foscarnet-GanciclovirCytomegalovirus Retinitis Trial-4. Visual outcomes. Ophthalmology.1994; 101: 1250-1261.
Department of Medicine Faculty Listing
Research Interests Timeline
International journal of psychiatry in medicine. 2018 Jul 05; 53(4):256-272
World journal of virology. 2017 Nov 12; 6(4):59-72
Real-world patterns of therapy utilization and outcomes in 7098 genotype 1-6 HCV patients: Data from the trio network [Meeting Abstract]
Hepatology. 2017 October; (68th):585A